Benzinga | Nov 16, 2020 05:24PM EST

Predictive Oncology Q3 EPS $(0.46) Up From $(1.31) YoY, Sales $480.76K Down From $522.70K YoY

Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.46) per share. This is a 64.89 percent increase over losses of $(1.31) per share from the same period last year. The company reported $480.76 thousand in sales this quarter. This is a 8.02 percent decrease over sales of $522.70 thousand the same period last year.